{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T19:38:44Z","timestamp":1767382724032,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.tiv.2022.105353","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T21:11:57Z","timestamp":1648242717000},"page":"105353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Amending the U-SENS\u2122 skin sensitization test method for interfering auto-fluorescent chemicals"],"prefix":"10.1016","volume":"81","author":[{"given":"Nad\u00e8ge","family":"Ade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Teluob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anaelle","family":"Viricel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Piroird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Al\u00e9p\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.tiv.2022.105353_bb0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2131\/jts.43.407","article-title":"Expansion of the applicability domain for highly volatile substances on the short time exposure test method and the predictive performance in assessing eye irritation potential","volume":"43","author":"Abo","year":"2018","journal-title":"J. Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.tiv.2022.105353_bb0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/15476910600978038","article-title":"Activation of U937 cells by contact sensitizers: CD86 expression is independent of apoptosis","volume":"3","author":"Ade","year":"2006","journal-title":"J. Immunotoxicol."},{"issue":"1 Pt","key":"10.1016\/j.tiv.2022.105353_bb0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tiv.2015.09.028","article-title":"Prospective multicentre study of the U-SENS test method for skin sensitization testing","volume":"30","author":"Al\u00e9p\u00e9e","year":"2015","journal-title":"Toxicol. in Vitro"},{"issue":"4","key":"10.1016\/j.tiv.2022.105353_bb0020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.tiv.2015.02.005","article-title":"Use of HPLC\/UPLC-spectrophotometry for detection of formazan in in vitro reconstructed human tissue (RhT)-based test methods employing the MTT-reduction assay to expand their applicability to strongly coloured test chemicals","volume":"29","author":"Al\u00e9p\u00e9e","year":"2015","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2022.105353_bb0025","doi-asserted-by":"crossref","first-page":"104936","DOI":"10.1016\/j.yrtph.2021.104936","article-title":"Next generation risk assessment for skin sensitisation: a case study with propyl paraben","volume":"123","author":"Assaf Vandecasteele","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2022.105353_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/DER.0000000000000003","article-title":"Categorization of chemicals according to their relative human skin sensitizing potency","volume":"25","author":"Basketter","year":"2014","journal-title":"Dermatitis"},{"issue":"1","key":"10.1016\/j.tiv.2022.105353_bb0035","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1038\/s41598-020-60747-3","article-title":"High-throughput screening to predict chemical-assay interference","volume":"10","author":"Borrel","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2022.105353_bb0040","article-title":"Regulation (EC) No 1223\/2009 of the European parliament and the council of 30 November 2009 on cosmetic products., ed. E Commission, pp. L342:59\u2013209","author":"EC (European Commission)","year":"2009","journal-title":"Off. J. Eur. Union"},{"year":"2019","author":"EC (European Commission), Joint Research Centre (JRC)","series-title":"EURL ECVAM dataset on alternative methods to animal experimentation (DB-ALM) - DB-ALM Protocol no. 183: U937 Cell Line Activation Test for Skin Sensitisation (U-SENSTM)","key":"10.1016\/j.tiv.2022.105353_bb0045"},{"key":"10.1016\/j.tiv.2022.105353_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104755","article-title":"Read-across can increase confidence in the next generation risk assessment for skin sensitisation: a case study with resorcinol","volume":"117","author":"Gautier","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2022.105353_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104721","article-title":"Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients","volume":"116","author":"Gilmour","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.tiv.2022.105353_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/17435390.2013.829590","article-title":"Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests","volume":"9","author":"Guadagnini","year":"2015","journal-title":"Nanotoxicology."},{"issue":"5","key":"10.1016\/j.tiv.2022.105353_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/026119290403200503","article-title":"A modular approach to the ECVAM principles on test validity","volume":"32","author":"Hartung","year":"2004","journal-title":"Altern. Lab. Anim"},{"issue":"5","key":"10.1016\/j.tiv.2022.105353_bb0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0536.1987.tb01493.x","article-title":"The sensitizing capacity of sulfuretin","volume":"17","author":"Hausen","year":"1987","journal-title":"Contact Dermatitis"},{"issue":"5","key":"10.1016\/j.tiv.2022.105353_bb0075","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10408444.2018.1429385","article-title":"Non-animal methods to predict skin sensitization (I): the cosmetics Europe database","volume":"48","author":"Hoffmann","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"issue":"5","key":"10.1016\/j.tiv.2022.105353_bb0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10408444.2018.1429386","article-title":"Non-animal methods to predict skin sensitization (II): an assessment of defined approaches","volume":"48","author":"Kleinstreuer","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.tiv.2022.105353_bb0085","first-page":"95","article-title":"Extending the applicability domain of the human cell line activation test (h-CLAT)","volume":"38","author":"Mewes","year":"2021","journal-title":"ALTEX."},{"year":"2005","author":"OECD","series-title":"Guidance Document on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment: OECD Series on Testing and Assessment, Number 34 (ENV\/JM\/MONO(2005)14)","key":"10.1016\/j.tiv.2022.105353_bb0090"},{"year":"2014","author":"OECD","series-title":"The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins, OECD Series on Testing and Assessment, No. 168","key":"10.1016\/j.tiv.2022.105353_bb0095"},{"year":"2018","author":"OECD","series-title":"Test No. 442D: In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method, OECD Guidelines for the Testing of Chemicals, Section 4","key":"10.1016\/j.tiv.2022.105353_bb0100"},{"year":"2018","author":"OECD","series-title":"Test No. 442E: In Vitro Skin Sensitisation: In Vitro Skin Sensitisation assays addressing the Key Event on activation of dendritic cells on the Adverse Outcome Pathway for Skin Sensitisation. OECD Guidelines for the Testing of Chemicals, Section 4","key":"10.1016\/j.tiv.2022.105353_bb0105"},{"year":"2021","author":"OECD","series-title":"Test No. 442C: In Chemico Skin Sensitisation: Assays Addressing the Adverse Outcome Pathway Key Event on Covalent Binding to Proteins, OECD Guidelines for the Testing of Chemicals, Section 4","key":"10.1016\/j.tiv.2022.105353_bb0110"},{"year":"2021","author":"OECD","series-title":"Guideline No. 497: Defined Approaches on Skin Sensitisation, OECD Guidelines for the Testing of Chemicals, Section 4","key":"10.1016\/j.tiv.2022.105353_bb0115"},{"key":"10.1016\/j.tiv.2022.105353_bb0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yrtph.2016.12.009","article-title":"Evaluation of in vitro assays for the assessment of the skin sensitization hazard of functional polysiloxanes and silanes","volume":"84","author":"Petry","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.tiv.2022.105353_bb0125","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.tiv.2015.03.009","article-title":"The myeloid U937 skin sensitization test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization","volume":"29","author":"Piroird","year":"2015","journal-title":"Toxicol. in Vitro"},{"issue":"1","key":"10.1016\/j.tiv.2022.105353_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/toxsci\/kfaa137","article-title":"Refinement of the peroxidase peptide reactivity assay and prediction model for assessing skin sensitization potential","volume":"178","author":"Ryan","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.tiv.2022.105353_bb0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ijc.2910170504","article-title":"Establishment and characterization of a human histiocytic lymphoma cell line (U-937)","volume":"17","author":"Sundstr\u00f6m","year":"1976","journal-title":"Int. J. Cancer"},{"year":"2019","author":"UN","series-title":"Globally harmonized system of classification and labelling of chemicals (GHS)","key":"10.1016\/j.tiv.2022.105353_bb0140"},{"issue":"2","key":"10.1016\/j.tiv.2022.105353_bb0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/fcp.12414","article-title":"Characterization of sulfuretin as a depigmenting agent","volume":"33","author":"Zhou","year":"2019","journal-title":"Fundam. Clin. Pharmacol."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233322000509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233322000509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:40:52Z","timestamp":1760136052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233322000509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"alternative-id":["S0887233322000509"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2022.105353","relation":{},"ISSN":["0887-2333"],"issn-type":[{"type":"print","value":"0887-2333"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amending the U-SENS\u2122 skin sensitization test method for interfering auto-fluorescent chemicals","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2022.105353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105353"}}